Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cleveland Biolabs Inc (NASDAQ:CBLI)

3.85
Delayed Data
As of 3:59pm ET
 -0.11 / -2.78%
Today’s Change
1.84
Today|||52-Week Range
13.80
-32.46%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues562.1K415.1K1.4M607.3K
 
 
 
 
 
Depreciation And Amortization536.7K78.0K76.6K38.6K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses4.0M3.8M4.8M3.9M
 
 
 
 
 
Research And Development2.3M2.1M2.8M1.6M
 
 
 
 
 
Total Operating Expenses4.6M3.9M4.8M3.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.0M-3.4M-3.5M-3.3M
 
 
 
 
 
Extraordinary Credit412.1K--998.9K0.00
 
 
 
Extraordinary Charge0.00-836.3K0.00-49.4K
 
 
 
Pre-Tax Equity Earnings-----285.5K-247.6K
 
 
 
Interest Expense On Debt623.8K--78.9K446.4K
 
 
 
 
Other Expenses92.6K-340.6K13.5M356.3K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.1M-4.6M10.7M-3.7M
 
 
 
 
 
Minority Interest-170.4K-519.5K-588.0K-48.2K
 
 
 
 
 
Net Income-4.0M-4.1M11.3M-3.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.6M2.9M2.9M3.2M
 
 
 
 
 
Shares To Calculate EPS Diluted2.6M2.9M2.9M3.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.60-$1.40$79.00-$1.14
 
 
 
 
 
EPS Diluted-$1.60-$1.40$3.95-$1.14